JO
HSTO

John Overdeck’s Histogen Inc. Common Stock HSTO Stock Holding History

John Overdeck’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,250
Closed -$433K – 3589
2018
Q4 		$433K Buy
1,250
+1,105
+762% +$859K ﹤0.01% 2206
2018
Q3 		$168K Buy
+145
New +$134K ﹤0.01% 3038
2018
Q2 		– Sell
-98
Closed -$115K – 3774
2018
Q1 		$115K Buy
+98
New +$108K ﹤0.01% 3029

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $58.9B AUM 51.73% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

John Overdeck's HSTO Position: Q1 2019 in Review

John Overdeck sold out of Histogen Inc. Common Stock (HSTO) in Q1 2019, closing a stake of 1,250 shares — an estimated $433K sold.

John Overdeck first reported a position in HSTO in Q1 2018 and held it in 3 quarters. The position peaked at $433K in Q4 2018. 42 funds tracked by Wall St. Rank hold HSTO as of Q1 2019.

  • John Overdeck reported no remaining Histogen Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • John Overdeck sold 1,250 Histogen Inc. Common Stock shares in Q1 2019, an estimated $433K.
  • John Overdeck first reported a position in Histogen Inc. Common Stock in Q1 2018 and held it in 3 quarters.
  • John Overdeck's Histogen Inc. Common Stock position peaked at $433K in Q4 2018.
  • 42 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q1 2019.

Based on Two Sigma Investments's 13F filing for Q1 2019, filed 15 May 2019.